scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PLoSO...5.9986M |
P356 | DOI | 10.1371/JOURNAL.PONE.0009986 |
P8608 | Fatcat ID | release_dch47c3zjfcpnix5fqbckyhlju |
P932 | PMC publication ID | 2848673 |
P698 | PubMed publication ID | 20376320 |
P5875 | ResearchGate publication ID | 43074229 |
P50 | author | Shinji Makino | Q88425988 |
Nandadeva Lokugamage | Q117812116 | ||
Tetsuro Ikegami | Q40311693 | ||
P2093 | author name string | C J Peters | |
Aya Zamoto-Niikura | |||
Kaori Terasaki | |||
John C Morrill | |||
Naoko Yoshikawa-Iwata | |||
Sungyong Won | |||
P2860 | cites work | Binding of Sindbis virus to cell surface heparan sulfate | Q27469562 |
Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus | Q27472877 | ||
Glycosaminoglycan binding properties of natural venezuelan equine encephalitis virus isolates | Q27473077 | ||
Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry | Q27478367 | ||
Minority memory genomes can influence the evolution of HIV-1 quasispecies in vivo. | Q51930420 | ||
Quasispecies dynamics and fixation of a synonymous mutation in hantavirus transmission | Q60031856 | ||
RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses | Q27487321 | ||
Genetic Analysis of Viruses Associated with Emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-01 | Q27489550 | ||
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population | Q29616266 | ||
TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. | Q33198557 | ||
A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. | Q33316823 | ||
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation | Q33406230 | ||
Evolution to predominance of swine influenza virus hemagglutinin mutants of predictable phenotype during single infections of the natural host | Q33662845 | ||
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system | Q33755025 | ||
NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. | Q35024013 | ||
Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus | Q35041237 | ||
Rift Valley fever: an uninvited zoonosis in the Arabian peninsula | Q35077306 | ||
Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor | Q35635252 | ||
Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses | Q35702608 | ||
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis | Q36315241 | ||
Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals | Q36484009 | ||
Hidden virulence determinants in a viral quasispecies in vivo | Q36949693 | ||
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies | Q39240187 | ||
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination | Q40233684 | ||
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene | Q40311587 | ||
Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. | Q40453546 | ||
Rift Valley fever outbreak--Kenya, November 2006-January 2007. | Q40458723 | ||
Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus | Q40498246 | ||
Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. | Q40632227 | ||
Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle | Q40645625 | ||
Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus | Q40653641 | ||
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
Rift Valley fever epizootic in the central highlands of Madagascar | Q40727647 | ||
Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies | Q40755091 | ||
Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine | Q40759549 | ||
Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins | Q40775631 | ||
Experimental Rift Valley fever in rhesus macaques | Q40789442 | ||
Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats | Q40798305 | ||
Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator | Q40806370 | ||
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development | Q40814834 | ||
Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters | Q40825493 | ||
Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep | Q40858817 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Rift Valley fever | Q326638 |
virulence | Q1460232 | ||
Rift Valley fever virus | Q14276794 | ||
Rift Valley fever phlebovirus | Q24809101 | ||
P304 | page(s) | e9986 | |
P577 | publication date | 2010-04-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA | |
P478 | volume | 5 |
Q62486031 | A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008-2010 |
Q59335452 | A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice |
Q37956499 | Animal models of Rift Valley fever virus infection |
Q37509225 | Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR. |
Q28486276 | Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus |
Q35126733 | Development of a novel, single-cycle replicable rift valley Fever vaccine |
Q47562012 | Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model |
Q28085230 | Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus |
Q21144476 | High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses |
Q37036679 | IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus |
Q92855169 | IFITM3 Clusters on Virus Containing Endosomes and Lysosomes Early in the Influenza A Infection of Human Airway Epithelial Cells |
Q34251382 | Innate immune response to Rift Valley fever virus in goats |
Q38376184 | Interplay between the Virus and Host in Rift Valley Fever Pathogenesis |
Q36652695 | Molecular biology and genetic diversity of Rift Valley fever virus |
Q33401592 | Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model |
Q35912398 | Protein Kinase R Degradation Is Essential for Rift Valley Fever Virus Infection and Is Regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 Ligase |
Q99711464 | Rift Valley Fever Virus Is Lethal in Different Inbred Mouse Strains Independent of Sex |
Q34475358 | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. |
Q37006803 | Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice |
Q34174444 | Rift valley fever: recent insights into pathogenesis and prevention |
Q36127490 | Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease |
Q84957526 | The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal |
Q36155392 | The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine |
Q34191969 | The pathogenesis of Rift Valley fever |
Q34097995 | Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. |
Search more.